# WCC Biomedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wcc-biomedical

- Industry: Healthcare IT
- Headquarters: Hsinchu, Taiwan - China
- Website: www.wccbiomedical.com
- Total disclosed funding: $14M
- Latest round: Series B (Apr 30, 2023)
- Investors on record: 5

## About

Founded in 2014 and based in Taiwan, China, WCC Biomedical operates as a health tech company that engages in the research and development of intradermal drug delivery platforms. The company has an operation center in Taipei. Dajiao Liu, the founder of the company, was a senior research scientist at Kodak and a professor at National Tsing Hua University in Taiwan. In 2021, the company joined the Japan External Trade Organization (JETRO). In June 2023, WCC Biomedical closed a round of series B funding. The company changed its name from Wincoat into WCC Biomedical in 2024.

The company is mainly engaged in the research and development of intradermal drug delivery platforms and related microneedle patches. The main products include medical microneedle patches, vaccine microneedle patches, medical beauty patches, etc. The independently developed drug delivery platform adopts the multi-layer microneedle platform technology WINMAPTM, which achieves the stability of the needle structure and the control of drug release. The products can be widely used in medical beauty care, medical materials, medicines, vaccines, etc.

The company generates revenue by providing intradermal drug delivery platforms and related microneedle patches.

## Funding rounds

- Series B, Apr 30, 2023, $14M — CDIB Capital Group, CTBC Bank, Hua Nan Venture Capital, Taiwan Cooperative Venture Capital, Synmosa

## Investors

- CDIB Capital Group (https://capitalatlas.ai/funds/cdib-capital-group) — Series B
- CTBC Bank — Series B
- Hua Nan Venture Capital (https://capitalatlas.ai/funds/hua-nan-venture-capital) — Series B
- Taiwan Cooperative Venture Capital (https://capitalatlas.ai/funds/taiwan-cooperative-venture-capital) — Series B
- Synmosa — Series B
